365 related articles for article (PubMed ID: 20636651)
21. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
Kemp R; Miller J; Lungley S; Baker M
N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
[TBL] [Abstract][Full Text] [Related]
22. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
23. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
24. New syringe acquisition and multi-person use of syringes among illegal drug users.
Richard AJ; Mosier V; Atkinson JS
J Public Health Policy; 2002; 23(3):324-43. PubMed ID: 12325289
[TBL] [Abstract][Full Text] [Related]
25. Assessing and prioritizing the preferences of injecting drug users in needle and syringe exchange service development.
Matheson C; Anthony GB; Bond C; Rossi MK
J Public Health (Oxf); 2008 Jun; 30(2):133-8. PubMed ID: 18436548
[TBL] [Abstract][Full Text] [Related]
26. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
[TBL] [Abstract][Full Text] [Related]
27. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
Islam M; Wodak A; Conigrave KM
Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
[TBL] [Abstract][Full Text] [Related]
29. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
30. The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment.
Hopwood M; Southgate E; Kippax S; Bammer G; Isaac-Toua G; MacDonald M
Aust N Z J Public Health; 2003 Oct; 27(5):551-5. PubMed ID: 14651404
[TBL] [Abstract][Full Text] [Related]
31. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
[TBL] [Abstract][Full Text] [Related]
32. Drug use and HIV risk practices of secondary and primary needle exchange users.
Huo D; Bailey SL; Hershow RC; Ouellet L
AIDS Educ Prev; 2005 Apr; 17(2):170-84. PubMed ID: 15899754
[TBL] [Abstract][Full Text] [Related]
33. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
Islam MM; Conigrave KM; Stern T
Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
[TBL] [Abstract][Full Text] [Related]
34. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
Takács IG; Demetrovics Z
Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
[TBL] [Abstract][Full Text] [Related]
36. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.
Miller CL; Tyndall M; Spittal P; Li K; Palepu A; Schechter MT
J Urban Health; 2002 Jun; 79(2):257-65. PubMed ID: 12023501
[TBL] [Abstract][Full Text] [Related]
37. Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan.
Todd CS; Abed AM; Scott PT; Botros BA; Safi N; Earhart KC; Strathdee SA
Am J Drug Alcohol Abuse; 2008; 34(1):91-100. PubMed ID: 18161647
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
[TBL] [Abstract][Full Text] [Related]
39. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.
Gyarmathy VA; Neaigus A; Mitchell MM; Ujhelyi E
Drug Alcohol Depend; 2009 Mar; 100(3):240-7. PubMed ID: 19058925
[TBL] [Abstract][Full Text] [Related]
40. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand.
Kerr T; Fairbairn N; Hayashi K; Suwannawong P; Kaplan K; Zhang R; Wood E
Drug Alcohol Rev; 2010 Mar; 29(2):157-61. PubMed ID: 20447223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
